| ITCI Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the ITCI shares outstanding history going back to 11/4/2013:
Also see: ITCI Market Cap History ITCI YTD Return |
ITCI Shares Outstanding History — Intra-Cellular Therapies Share Count Over Time
As of 3/10/2025 Intra-Cellular Therapies has 106.52 million ITCI shares outstanding. Investors often track the ITCI shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows ITCI share count trends over time, with 49 historical shares outstanding datapoints presented, dating back to 11/4/2013.
| ITCI Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ITCI Historical Shares Outstanding: +14.85% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ITCI Stock Price Chart |
| About Intra-Cellular Therapies Inc |
| Intra-Cellular Therapies, Inc. is a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) disorders. Co. leverages intracellular approach to develop treatments for people living with complex psychiatric and neurologic diseases. Co.'s product, CAPLYTA (lumateperone), is an oral, once daily atypical antipsychotic approved in adults for the treatment of schizophrenia and the treatment of depressive episodes associated with bipolar I or II disorder (bipolar depression) as monotherapy and as adjunctive therapy with lithium or valproate. We show 49 historical shares outstanding datapoints in our coverage of ITCI's shares outstanding history. Understanding the changing numbers of ITCI shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like ITCI versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching ITCI by allowing them to research ITCI shares outstanding history as well as any other stock in our coverage universe. |
| ITCI Current Stock Quote |
Quotes delayed 20 minutes  Free ITCI Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Shares Outstanding Importance | |
|
Video: Shares Outstanding Importance
| ITCI Share Performance |
| Shares Outstanding Peers |
| Intra-Cellular Therapies (ITCI) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
ITGR Shares Outstanding History ITOS Shares Outstanding History ITUS Shares Outstanding History IVC Shares Outstanding History IVF Shares Outstanding History IVTY Shares Outstanding History IVVD Shares Outstanding History IXHL Shares Outstanding History JAGX Shares Outstanding History JAN Shares Outstanding History More Healthcare companies » |
ITCI Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
